Attenuated inhibition of L-type calcium currents by troglitazone in fructose-fed rat cardiac ventricular myocytes

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 1, 2004, Pages 109-116

  Arikawa, Masaya ^a   Takahashi, Naohiko ^a,b   Kira, Tetsuya ^a   Hara, Masahide ^a   Yoshimatsu, Hironobu ^a   Saikawa, Tetsunori ^b  

^a OITA UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

Calcium; Diabetes mellitus; Electrophysiology; Myocytes

Indexed keywords

CALCIUM CHANNEL L TYPE; FRUCTOSE; GLUCOSE; INSULIN; TROGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CALCIUM CURRENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEART MUSCLE CELL; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEADY STATE; STREPTOZOCIN DIABETES; VOLTAGE CLAMP;

ANIMALS; CALCIUM CHANNELS, L-TYPE; CHROMANS; DIET; ELECTROPHYSIOLOGY; FRUCTOSE; HYPOGLYCEMIC AGENTS; MALE; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; THIAZOLIDINEDIONES;

EID: 3042699619     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200407000-00015     Document Type: Article

References (35)

1. Garcia MJ, MacNamara MP, Gordon T, et al. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974;23:105-111.
2. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure (the Framingham Heart Study). Am J Cardiol. 1974;34: 29-34.
3. Regan TJ, Lyons MM, Ahmed SS, et al. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest. 1977;60:885-899.
4. Tsuchida K, Watajima H, Otomo S. Calcium current in rat diabetic ventricular myocytes. Am J Physiol. 1994;267:H2280-H2289.
5. 2+ currents in ventricular myocytes from rats with chronic diabetes. Am J Physiol. 1995;269:H1288-H1296.
6. Chattou S, Diacono J, Feubray D. Decrease in sodium-calcium exchange and calcium currents in diabetic rat ventricular myocytes, Acta Physiol Scand. 1999;166:137-144.
7. 2+ channels during the development of diabetic cardiomyopathy. Mol Cell Biochem. 1992; 109:173-179.
8. Heijnis JB, Mathy MJ, Zwieten AV. Effects of various calcium antagonists in isolated perfused hearts from diabetic and age-matched control rats. J Cardiovasc Pharmacol. 1991;17:983-989.
9. 2+ channel currents in vascular smooth muscle cells from experimental diabetic rats. Am J Physiol. 2000;278:H714-H722.
10. Arikawa M, Takahashi N, Kira T, et al. Enhanced inhibition of L-type calcium currents by troglitazone in streptozotocin-induced diabetic rat cardiac ventricular myocytes. Br J Pharmacol. 2002;136:803-810.
11. Suter SL, Nolan JJ, Wallase P, et al. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care. 1992;15: 193-203.
12. Chazzi MN, Perez JE, Antonuci TK, et al. Cardiac and glycemic benefits of troglitazone treatment in NIDDM. Diabetes. 1997;46:433-439.
13. Hwang IS, Ho H, Hoffman BB, et al. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 1987;10:512-516.
14. + currents in rat heart: role of insulin. J Physiol. 1998;507:485-496.
15. Hamil OP, Marty A, Neher E, et al. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100.
16. Belles N, Malecot CO, Hescheler J, et al. Run-down of the Ca current during long whole-cell recordings in guinea pig heart cells. Pflugers Arch. 1988;411:353-360.
17. Jourdon P, Feuvray D. Calcium and potassium currents in ventricular myocytes isolated from diabetic rats. J Physiol. 1993;470:411-429.
18. 2+ current in diabetic rat cardiomyocytes. Am J Physiol. 1998;274:H1849-H1857.
19. Katoh Y, Hashimoto S, Kimura J, et al. Inhibitory action of troglitazone, an insulin-sensitizing agent, on the calcium current in cardiac ventricular cells of guinea pig. Jpn J Pharmacol. 2000;82:102-109.
20. Nakajima T, Iwasawa K, Oomura H, et al. Troglitazone inhibits voltage-dependent calcium currents in guinea pig cardiac myocytes. Circulation. 1999;99:2942-2950.
21. Nakamura Y, Ohya Y, Onaka U, et al. Inhibitory action of insulin-sensitizing agents on calcium channels in smooth muscle cells from resistance arteries of guinea-pig. Br J Pharmacol. 1998;123:675-682.
22. Buchanan TA, Meehan WP, Jeng YY, et al. Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect. J Clin Invest. 1995;96: 354-360.
23. Standley PR, Zhang F, Ram JL, et al. Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Invest. 1991;88:1230-1236.
24. 2+ current in rat cardiac myocytes. Cardiovasc Res. 1999;42:113-120.
25. 2+ current in human atrial myocytes by insulin. Cardiovasc Res. 1999;44:390-397.
26. 2+ channel by PN 200-110 in heart and vascular smooth muscle. Mol Cell Biochem. 1992;117:93-106.
27. 2+ current in Type II diabetes patients-a possible link to cardiac dysfunction in diabetes mellitus. Diabetologia. 2001;44:269-269.
28. Goldfine ID, Maddux BA, Youngren JF, et al. Membrane glycoprotein PC-1 and insulin resistance. Mol Cell Biochem. 1998;182:177-184.
29. Yuan TH, Kerns WP II, Tomaszewski CA, et al. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol. 1999;37:463-474.
30. Boyer EW, Shannon M. Treatment of calcium-channel-blocker intoxication with insulin infusion. N Engl J Med. 2001;344:1721-1722.
31. Salhanick SD, Shannon MW. Management of calcium channel antagonist overdose. Drag Saf 2003;26:65-79.
32. Shibata H, Nii S, Kobayashi M, et al. Phase I study of a new hypoglycemic agent CS-045 in healthy volunteers: safety and pharmacokinetics in reported administration [in Japanese]. Rinsho Iyaku. 1993;9:1519-1537.
33. Simonson DC. Etiology and prevalence of hypertension in diabetic patients. Diabetes Care. 1988;11:821-822.
34. Zhang F, Sowers JR, Ram JL, et al. Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension. 1994;24:170-175.
35. Nakamura Y, Ohya Y, Onaka U, et al. Inhibitory action of insulin-sensitizing agents on calcium channels in smooth muscle cells from resistance arteries of guinea-pig. Br J Pharmacol. 1998;123:675-682.